Regencell Bioscience is the top performing pharma stock YTD
Source: SeekingAlpha
2025-12-22 23:47:10 ET
More on healthcare stocks
- My S&P 500 Prediction On Sector Outperformers And Laggards In 2026
- IHI: A Passive ETF For Medical Device Exposure
- Regencell Bioscience: Material Weaknesses Add To Woes
- Abivax is the top performing biotechnology stock YTD
- PACS Group is the top performing healthcare facilities' stock YTD
Read the full article on Seeking Alpha
For further details see:
Regencell Bioscience is the top performing pharma stock YTD
Vanguard Health Care
NASDAQ: VHT
VHT Trading
-0.22% G/L:
$278.01 Last:
69,609 Volume:
$278.70 Open:
VHT Latest News
August 25, 2025 09:00:00 am
Vanguard Announces Intent to Revert Diversification Status for Two Funds
July 21, 2025 07:45:00 am
Here's Why Vanguard's Worst-Performing Sector ETF Is a No-Brainer Buy Right Now
